Infectious Diseases
News
HPV vaccine rates perpetuate racial and geographic cancer disparities
News
Interferon-free regimen benefits HCV-infected liver transplant recipients
Key clinical point: An oral, interferon-free drug combination produced a 97% sustained virologic response rate in liver transplant recipients with...
Video
VIDEO: West African Ebola scope makes control uncertain
Conference Coverage
Drug combination successful in hepatitis C plus HIV
Key clinical point: Hepatitis C can be treated successfully in patients with HIV using ledipasvir and sofosbuvir. Major finding: Ledipasvir plus...
Conference Coverage
Sofosbuvir-containing regimens dominate hepatitis C treatment
Key clinical point: Real-world results with sofosbuvir-containing regimens are consistent with clinical trial results. Major finding: Sofosbuvir-...
Video
VIDEO: Lamivudine under study for Ebola
Conference Coverage
Achieving sustained response key to successful HCV treatment
Key clinical point: Achieving a sustained virologic response to hepatitis C treatment improved long-term outcomes. Major finding: Achieving a...
News
Pneumococcal conjugate vaccine decreased risk of sinusitis, pneumonia in youngest kids
Key clinical point: Introduction of PCV7 and PCV13 into childhood vaccination program significantly reduced hospitalizations for sinusitis in...
News
ABT-450 combo achieves high SVR12 in hepatitis C
Key clinical point: A formulation of ABT-450 with ritonavir, ombitasvir, and dasabuvir, given with ribavirin, can yield sustained viral response...
News
Viral suppression of HCV yielded improvements in neural health
Key clinical point: Viral suppression in HCV-infected patients improved neural health as measured by magnetic resonance spectroscopy. Major...
News
Sofosbuvir plus GS-5816 yielded high SVR rates in genotype 3 HCV patients
Key clinical point: Sofosbuvir plus GS-5816 was well tolerated and achieved high SVR rates among treatment-naive patients with chronic genotype 3...